ATE181923T1 - 3''-desmethoxyderivate von erythromycin und azithromycin - Google Patents

3''-desmethoxyderivate von erythromycin und azithromycin

Info

Publication number
ATE181923T1
ATE181923T1 AT95906455T AT95906455T ATE181923T1 AT E181923 T1 ATE181923 T1 AT E181923T1 AT 95906455 T AT95906455 T AT 95906455T AT 95906455 T AT95906455 T AT 95906455T AT E181923 T1 ATE181923 T1 AT E181923T1
Authority
AT
Austria
Prior art keywords
azithromycin
erythromycin
alkyl
image
desmethoxy derivatives
Prior art date
Application number
AT95906455T
Other languages
English (en)
Inventor
Bingwei V Yang
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Application granted granted Critical
Publication of ATE181923T1 publication Critical patent/ATE181923T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
AT95906455T 1994-03-04 1995-02-02 3''-desmethoxyderivate von erythromycin und azithromycin ATE181923T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/206,551 US5441939A (en) 1994-03-04 1994-03-04 3"-desmethoxy derivatives of erythromycin and azithromycin

Publications (1)

Publication Number Publication Date
ATE181923T1 true ATE181923T1 (de) 1999-07-15

Family

ID=22766886

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95906455T ATE181923T1 (de) 1994-03-04 1995-02-02 3''-desmethoxyderivate von erythromycin und azithromycin

Country Status (11)

Country Link
US (1) US5441939A (de)
EP (1) EP0748329B1 (de)
JP (1) JP3083102B2 (de)
AT (1) ATE181923T1 (de)
CA (1) CA2184734C (de)
DE (1) DE69510659T2 (de)
DK (1) DK0748329T3 (de)
ES (1) ES2133175T3 (de)
FI (1) FI110780B (de)
GR (1) GR3031092T3 (de)
WO (1) WO1995023808A1 (de)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0537506U (ja) * 1991-10-31 1993-05-21 横浜ゴム株式会社 タイヤ滑り止め装置
HN1998000086A (es) 1997-06-11 1999-03-08 Pfizer Prod Inc Derivados de 9 - desofo - 9 aza - 9a - homoeritromicina a - c - 4 sustituidos.
US6407074B1 (en) 1997-06-11 2002-06-18 Pfizer Inc C-4″-substituted macrolide derivatives
HN1998000074A (es) * 1997-06-11 1999-01-08 Pfizer Prod Inc Derivados de macrolidos c-4 sustituidos
US6861411B1 (en) 1997-12-02 2005-03-01 Pfizer, Inc. Method of treating eye infections with azithromycin
AP1060A (en) * 1998-01-02 2002-04-23 Pfizer Prod Inc Novel erythromycin derivatives.
AP9801420A0 (en) * 1998-01-02 1998-12-31 Pfizer Prod Inc Novel macrolides.
US6100240A (en) * 1998-10-09 2000-08-08 Pfizer Inc Macrolide derivatives
CA2292359C (en) * 1999-01-28 2004-09-28 Pfizer Products Inc. Novel azalides and methods of making same
US6239113B1 (en) * 1999-03-31 2001-05-29 Insite Vision, Incorporated Topical treatment or prevention of ocular infections
US7056893B2 (en) * 1999-03-31 2006-06-06 Insite Vision, Inc. Topical treatment for prevention of ocular infections
EP1189912B1 (de) * 1999-05-18 2008-04-16 Pfizer Products Inc. Neue kristalline formen eines macrolidantibiotikums
IL145739A0 (en) * 1999-05-24 2002-07-25 Pfizer Prod Inc 13-methyl-erythromycin derivatives
AU2001214115A1 (en) * 2000-08-01 2002-02-13 Habil F. Khorakiwala Process for the preparation of anhydrous azithromycin
DE60114028T2 (de) 2000-08-23 2006-07-13 Wockhardt Ltd. Verfahren zur herstellung von wasserfreiem azithromycin
WO2002088158A1 (en) 2001-04-27 2002-11-07 Pfizer Products Inc. Process for preparing 4'-substituted-9-deoxo-9a-aza-9a-homoerythromycin a derivatives
US7273853B2 (en) * 2002-05-13 2007-09-25 Enanta Pharmaceuticals, Inc. 6-11 bicyclic ketolide derivatives
US6878691B2 (en) * 2002-05-13 2005-04-12 Enanta Pharmaceuticals, Inc. 6-11 bicyclic ketolide derivatives
US7064110B2 (en) * 2002-05-13 2006-06-20 Enanta Pharmaceuticals, Inc. 6-11 bicycle ketolide derivatives
WO2005061526A1 (en) * 2003-11-20 2005-07-07 Enanta Pharmaceuticals, Inc. 6-11 bicyclic ketolide drivatives
CN101955508B (zh) * 2003-11-20 2015-04-15 埃纳恩塔制药公司 6-11双环酮大环内酯衍生物
WO2005067564A2 (en) * 2004-01-07 2005-07-28 Enanta Pharmaceuticals, Inc. 6-11 bicyclic erythromycin derivatives
US20060116336A1 (en) * 2004-03-17 2006-06-01 American Pharmaceutical Partners, Inc. Lyophilized azithromycin formulation
US7468428B2 (en) * 2004-03-17 2008-12-23 App Pharmaceuticals, Llc Lyophilized azithromycin formulation
US20060046970A1 (en) * 2004-08-31 2006-03-02 Insite Vision Incorporated Topical otic compositions and methods of topical treatment of prevention of otic infections
US7384922B2 (en) * 2005-05-04 2008-06-10 Enanta Pharmaceuticals, Inc. 6-11 bridged oxime erythromycin derivatives
US8354383B2 (en) * 2007-09-17 2013-01-15 Enanta Pharmaceuticals, Inc. 6,11-bridged biaryl macrolides
US8273720B2 (en) * 2007-09-17 2012-09-25 Enanta Pharmaceuticals, Inc. 6,11-bicyclolides: bridged biaryl macrolide derivatives
KR101223158B1 (ko) * 2007-09-17 2013-01-17 이난타 파마슈티칼스, 인코포레이티드 6,11-다리걸친 바이아릴 매크로라이드
EP3612543B1 (de) 2017-04-20 2022-11-23 Rising Tide Foundation Ein phosphonium-ion enthaltende azithromycin-derivate als antikrebsmittel
US11427606B2 (en) 2017-04-20 2022-08-30 Rising Tide Foundation Azithromycin derivatives containing a phosphonium ion as anticancer agents
WO2018195434A1 (en) 2017-04-21 2018-10-25 Lisanti Michael P Vitamin c and doxycycline: a synthetic lethal combination therapy for eradicating cancer stem cells (cscs)
WO2018195446A1 (en) 2017-04-21 2018-10-25 Lisanti Michael P Targeting hypoxic cancer stem cells (cscs) with doxycycline: implications for improving anti-angiogenic therapy
US11160821B2 (en) 2017-05-19 2021-11-02 Lunella Biotech, Inc. Antimitoscins: targeted inhibitors of mitochondrial biogenesis for eradicating cancer stem cells
WO2018213764A1 (en) 2017-05-19 2018-11-22 Lunella Biotech, Inc. Companion diagnostics for mitochondrial inhibitors
CU20190106A7 (es) 2017-06-26 2020-11-30 Lunella Biotech Inc Mitocetoscinas: agentes terapéuticos basados en mitocondrias que fijan como objetivo el metabolismo de cetonas en células cancerosas

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI8110592A8 (en) * 1981-03-06 1996-06-30 Pliva Pharm & Chem Works Process for preparing of n-methyl-11-aza-10-deoxo-10-dihydroerythromycine a and derivatives thereof
US4382085A (en) * 1982-03-01 1983-05-03 Pfizer Inc. 4"-Epi erythromycin A and derivatives thereof as useful antibacterial agents
US4474768A (en) * 1982-07-19 1984-10-02 Pfizer Inc. N-Methyl 11-aza-10-deoxo-10-dihydro-erytromycin A, intermediates therefor
US4526889A (en) * 1982-11-15 1985-07-02 Pfizer Inc. Epimeric azahomoerythromycin A derivative, intermediates and method of use
SI8311553A8 (en) * 1983-07-18 1995-06-30 Pliva Pharm & Chem Works Process for preparing 7,16-dioxa-2-aza-10-0-cladynosil-12-0-desosaminyl-4,5-dihydroxy-6- ethyl-3,5,9,11,13,15-hexamethylbicyclo (11.2.1.) hexadeca-1(2)-ene-8-ones
JPS60126296A (ja) * 1983-12-13 1985-07-05 Kyowa Hakko Kogyo Co Ltd ３，３”，４”−トリ−ｏ−アシルスピラマイシン１
US4512982A (en) * 1984-04-13 1985-04-23 Pfizer Inc. 9α-Aza-9α-homoerythromycin compounds, pharmaceutical composition and therapeutic method
US4518590A (en) * 1984-04-13 1985-05-21 Pfizer Inc. 9α-Aza-9α-homoerythromycin compounds, pharmaceutical compositions and therapeutic method
GB8521402D0 (en) * 1985-08-28 1985-10-02 Beecham Group Plc Chemical compounds
US5912331A (en) * 1991-03-15 1999-06-15 Merck & Co., Inc. Process for the preparation of 9-deoxo-9(Z)-hydroxyiminoerythromycin A
CA2062932A1 (en) * 1991-03-15 1992-09-16 Robert R. Wilkening 9-deoxo-9(z)-hydroxyiminoerythromycin a and o-derivatives thereof
CA2064634C (en) * 1991-04-04 1998-08-04 James V. Heck 9-deoxo-8a-aza-8a-homoerythromycin a derivatives modified at the 4"- and8a-positions
CA2065222A1 (en) * 1991-04-09 1992-10-10 Robert R. Wilkening Process for the preparation of 8a-aza-8a-homoerythromycin cyclic iminoethers
JP6152837B2 (ja) 2014-09-26 2017-06-28 Ｊｆｅスチール株式会社 冷延鋼板の製造方法及び圧延機

Also Published As

Publication number Publication date
JPH09511498A (ja) 1997-11-18
WO1995023808A1 (en) 1995-09-08
DK0748329T3 (da) 1999-11-22
DE69510659D1 (en) 1999-08-12
JP3083102B2 (ja) 2000-09-04
FI951003A0 (fi) 1995-03-03
CA2184734C (en) 1999-08-03
CA2184734A1 (en) 1995-09-08
GR3031092T3 (en) 1999-12-31
FI951003L (fi) 1995-09-05
ES2133175T3 (es) 1999-09-01
EP0748329A1 (de) 1996-12-18
EP0748329B1 (de) 1999-07-07
FI110780B (fi) 2003-03-31
US5441939A (en) 1995-08-15
DE69510659T2 (de) 1999-10-21

Similar Documents

Publication Publication Date Title
DE69510659D1 (en) 3''-desmethoxyderivate von erythromycin und azithromycin
ATE205205T1 (de) Durch hetero-aromatische ring substituierte phenyloxazolidinone als antimikrobielles mittel
DK0706393T3 (da) Immun-undertrykkende og antiallergiske forbindelser, f.eks. N-(3-oxohexanoyl)homoserin-lacton
WO1996023788B1 (en) Hetero-aromatic ring substituted phenyloxazolidinone antimicrobials
NZ508918A (en) 2-(Purin-9-YL)-tetrahydrofuran-3,4-diol derivatives useful for the treatment of inflammation
NZ239165A (en) Drug conjugate (a-o-w-z) a -t, the crosslinking group containing a cycloalkyl ring, and pharmaceutical compositions
MX9408969A (es) Composisciones farmaceuticas que comprenden microparticulas biodegradables y biocompatibles para el tratamiento de transtornos psicoticos, su uso y procedimiento para prepararlas.
PT1021456E (pt) Derivados macrociclicos de eritromicinas a e b de anel de 13 membros
ATE124944T1 (de) Heterocyclische verbindungen mit antiemetischer und migräne unterdrückender wirkung und diese verbindungen enthaltende pharmazeutische zusammensetzungen.
ZA9710292B (en) Atherosclerosis treatment
CA2085345A1 (en) Pyrimidine nucleoside derivatives
TW354293B (en) Prodrugs of paclitaxel derivatives
AU2888892A (en) 3-ureido-benzodiazepinones useful as antagonists of cck or of gastrine
FI920349A0 (fi) Foerfarande foer framstaellning av nya tetrazolderivat och deras anvaendning.
EP1468692A3 (de) Verwendung von 2,6-Dialkyl-4-Silyl-Phenol Derivaten zur Behandlung von Xanthom
AU3458997A (en) Anti-beta-amyloid protein-induced cytotoxicity composition
TW350757B (en) Benzisoxazole derivatives and pesticidal compositions containing them
ES8200119A1 (es) Un procedimiento para la preparacion de un derivado de 2-de soxi-fortimicina a o b2-sustituidos.
TW354780B (en) 2-disubstituted cyclohexenyl and cyclohexyl antimicrobial agents
EP0424899A3 (en) Novel anthracycline glycoside derivatives and preparing method thereof
EP1074545A4 (de) Isochinolinsulfonamid-derivate und sie als aktiven bestandteil enthaltende medikamente
DK0381989T3 (da) 4-epi-4-amino-anthracycliner
PL364698A1 (en) Novel vitamin d analogues
DE69131774D1 (de) Antibakterielle penem-ester derivate
ATE196910T1 (de) 7-glykosyloxybenzopyranderivat und dieses enthaltendes antiallergisches mittel

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee